In Illinois, researchers discovered how the most deadly pediatric brain tumor, diffuse intrinsic pontine glioma, develops and found a compound that can flip the switch on cancer-promoting genes turning them off so the tumor shrinks. Researchers used biopsied tumor samples from patients to create the lab models and it took less than two years for them to make the discovery. Considering only 5 percent of children with this brain tumor survive, being able to shrink tumors and increase survival rates in animal models is giving major hope for children and their parents. Clinical trials will begin at the Ann & Robert H. Lurie Children’s Hospital of Chicago by the end of the year.
Latest article
Lights, Camera, Compassion: Natalie Portman promotes Uncaged Innovations’ cruelty-free leather alternative
In New York, A-list star Natalie Portman has signed on to promote leather alternatives developed and manufactured by Uncaged Innovations. Portman, a long-standing advocate...
Time for snackies! Dogs love BeneMeat’s cultivated meat treats
In Prague, BeneMeat, a cultivated meat company targeting pet food, revealed that 90% of dog owners participating in a 25-country “Try & Share” lab-grown...
Locus Fermentation Solutions raises $20 million
In Ohio, Locus Fermentation Solutions has closed an oversubscribed, $20-million investment in a convertible note round at an equity valuation of $100 million. The...